Aijun Lu

Title: Aijun Lu: Innovator in Antipsychotic Drug Development

Introduction

Aijun Lu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antipsychotic medications. His work focuses on innovative compounds that aim to improve treatment options for various mental health disorders.

Latest Patents

Aijun Lu holds a patent for a compound known as 1,5-dihydro-2,4-benzodiazepine-3-one derivative. This derivative is designed to act on 5-HT and 5-HT receptors. The selectivity for 5-HT is either superior or similar to that of pimavanserin. This compound is particularly useful in treating schizophrenia, Parkinson's disease, dementia-related behavioral disorders, and psychosis. The antipsychotic activity of this compound is comparable to that of pimavanserin, while also exhibiting fewer side effects, such as sedation and worsening of exercise. Additionally, it has lower cardiotoxicity compared to pimavanserin.

Career Highlights

Aijun Lu is currently associated with Jiangsu Nhwa Pharmaceutical Co., Ltd. His role in the company has allowed him to focus on the research and development of innovative pharmaceutical solutions. His dedication to improving mental health treatments has positioned him as a key figure in the industry.

Collaborations

Aijun Lu collaborates with several professionals in his field, including Peng Jing and Minquan Yu. These collaborations enhance the research and development process, leading to more effective pharmaceutical innovations.

Conclusion

Aijun Lu's contributions to the field of antipsychotic drug development highlight his commitment to improving mental health treatment options. His innovative work continues to pave the way for advancements in pharmaceuticals.